Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
NCT02579317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2022-03-28
Summary
Despite conscious intentions to remain abstinent, persons with substance use disorders often find that negative emotions and environmental cues automatically "trigger" drinking and other substance use. This study aims to test whether activating the baroreflex mechanism can be used "in the moment" to help resist drinking triggers. It consists of 3 phases (Recruitment, Intervention, Follow-up).
Stage 1: Trained research staff conduct a comprehensive clinical interview and questionnaires to assess participant's mood, substance use, and triggers. Participants are paired with a Primary Research Clinician (PRC) who will work with them during the intervention.
Stage 2: Approximately 4 weeks after intake into the Center for Great Expectations Intensive Outpatient program, an 8-week intervention begins. Pre-and post-intervention laboratory sessions occur at Cardiac Neuroscience Laboratory, Center of Alcohol Studies, Piscataway, NJ. Some participants take part in pre- and post-intervention neuroimaging sessions (Rutgers University Brain Imaging Center, Newark, NJ). Participants are randomized into an active intervention or control group after the pre-intervention lab session. They are given an iPhone and trained to use a paced breathing app that is pre-loaded onto the phone. Participants in both groups use their app any time they anticipate or experience a trigger to drink or use drugs. Participants are compensated for their use of the app and the time for participation. To ensure that participants are correctly performing the paced breathing task, their PRC visit with them weekly to provide coaching sessions using a computer-based biofeedback program. During the 4th week, ECG and respiration data are collected. Participants also complete questionnaires about mood and triggers, and provide feedback on the usefulness of the app.
During the lab sessions, participants complete a series of questionnaires and ECG, blood pressure and respiration are collected during four 5-minute tasks (resting baseline, non-resonance breathing, resonance breathing, and visual processing/attention). During the neuroimaging sessions, participants are placed in the scanner for structural scans and four 5-minute tasks (as tasks as previously noted); ECG and blood pressure are recorded.
Stage 3: Participants are re-contacted 1 and 3 months after the intervention to complete questionnaires about their quality of life across multiple domains and the usefulness of the app.
Conditions
- Substance Use Disorder
Interventions
- BEHAVIORAL
-
Resonance Breathing
Breathing is paced with a pre-installed iPhone app that includes a visual pacer.
- BEHAVIORAL
-
Non-Resonance Breathing
Breathing is paced with a pre-installed iPhone app that includes a visual pacer.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
Rutgers, The State University of New Jersey
lead OTHER
Principal Investigators
-
Jennifer Buckman, Ph.D. · Center of Alcohol Studies
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2020-03-31
- Completion
- 2020-06-30
Countries
- United States
Study Locations
More Related Trials
-
Neuroimmune Dysfunction in Alcohol Use Disorder
NCT04210713 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
NCT02966873 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Stress-related Predictor Profiles in Human Addiction
NCT03810924 ·Status: COMPLETED ·Phase: NA
-
The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates
NCT03311594 ·Status: COMPLETED ·Phase: PHASE1
-
Neural Mechanisms of Disulfiram Effects
NCT02735577 ·Status: COMPLETED ·Phase: PHASE4
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
Neurofeedback & Alcohol Dependence
NCT02486900 ·Status: COMPLETED ·Phase: NA
-
Glutamatergic Modulation of Disordered Alcohol Use
NCT02539511 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Endotoxin on Alcohol Consumption
NCT04527185 ·Status: COMPLETED ·Phase: PHASE2
-
fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD
NCT03595293 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Alcohol History on Effects of Nitrous Oxide - 9
NCT00000257 ·Status: COMPLETED ·Phase: NA
-
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Deep Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder
NCT02691390 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
NCT04084860 ·Status: RECRUITING ·Phase: PHASE2
-
Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues
NCT02939313 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
NCT02968537 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD
NCT02884908 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
NCT03018236 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
NCT04770025 ·Status: RECRUITING ·Phase: PHASE2
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Influence of TMS on Attention Modulation
NCT05611502 ·Status: RECRUITING ·Phase: NA
-
Evaluating Neuromodulation Technologies in Early Recovery
NCT01993277 ·Status: UNKNOWN ·Phase: NA